John Shipsey Insider Profile
4 Followers
John Shipsey, Chief Financial Officer at Smiths Group plc, holds 600.00 shares in Dechra Pharmaceuticals (Ticker: GB:DPH), holds 58.29K shares in Smiths Group plc (Ticker: GB:SMIN). Most recently, John Shipsey Bought ― shares of Dechra Pharmaceuticals on Oct 08, 2022 for an estimated value of 15.18K .
John Shipsey's Trading History
| DPHDechra Pharmaceuticals | Oct 08, 2022 | ― | Informative Buy | 15.18K | £23.20K | |
| SMINSmiths Group plc | Nov 01, 2021 | Chief Financial Officer | Uninformative Buy | ― | £1.57M |
You May Also Like
John Shipsey insider profile FAQ
What is the percentage of profitable transactions made by John Shipsey?
The percentage of profitable transactions made by John Shipsey is 50%.
What is the average return per transaction made by John Shipsey?
The average return per transaction made by John Shipsey is 4.60%.
What stocks does John Shipsey hold?
John Shipsey holds: GB:SMIN, GB:DPH stocks.
What was John Shipsey’s latest transaction?
John Shipsey’s latest transaction was an Informative Buy of 15.18K .
What was John Shipsey's most profitable transaction?
John Shipsey’s most profitable transaction was an Informative Buy of GB:DPH stock on October 8, 2022. The return on the trade was 53.00%.
What is John Shipsey's role in Smiths Group plc?
John Shipsey's role in Smiths Group plc is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
